NCT02198846

A Study to Compare Insulin Pump With Conventional Treatment in Type 2 Diabetes

A Study to Compare the Efficacy and Safety of Insulin Pump Treatment in Patients With Uncontrolled Type 2 Diabetes Mellitus

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Konkuk University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Insulin deficiency resulted from progressive beta cell failure and insulin resistance in type 2 diabetes requires exogenous insulin therapy, escaping from oral antihyperglycemic agents. Previous data have been suggested that continuous subcutaneous insulin infusion (CSII) does not only have efficacy in glucose control but also restore beta cell failure. The investigators plan to compare the efficacy/safety and beta cell function between insulin pump treatment and the intensification of conventional treatment in patients with uncontrolled type 2 diabetes.

Conditions

• Type 2 Diabetes Mellitus

Interventions

Type	Name	Description
DEVICE	insulin pump	stop any antihyperglycemic medication and convert to insulin pump
DRUG	conventional treatment	intensification of conventional treatment by adding oral antihyperglycemic agents or subcutaneous insulin (once / twice/ multiple injection)

Timeline

• Start date: 2014-06-01
• Primary completion: 2014-12-01
• Completion: 2015-03-01
• First posted: 2014-07-24
• Last updated: 2014-07-24

Locations

1 site across 1 country: South Korea